FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

Abeona Ther­a­peu­tics re­ceived FDA ap­proval for its cell ther­a­py to treat “but­ter­fly skin,” a rare ge­net­ic dis­ease that caus­es frag­ile skin and wounds. And its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER